Herpes Labialis
📧 Sign up to get email alerts when something new happens for Herpes Labialis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 [Phase 4]
A Phase 4 trial assessed once-daily valacyclovir (Valtrex) for reducing HSV-2 viral shedding in individuals newly diagnosed with genital her…
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis [NA]
Clinical trial update on the completion of a study evaluating whether consuming Lactobacillus GG and fructooligosaccharides affects immune r…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis [Phase 1]
Phase 1 trial evaluating safety and efficacy of Squaric Acid Dibutyl Ester for herpes labialis has completed with results posted.
-
CLINICAL_TRIALS research · 2017-03-09Clinical Trial Update: Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis [NA]
Clinical trial update for an unnamed topical natural health product being studied for herpes labialis. The current status of the study is un…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis [Phase 2]
A Phase 2, double-blind, randomized, placebo-controlled study evaluating topical VDO for herpes labialis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-04FDA Approved: FAMCICLOVIR — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic version of famciclovir.
-
FDA approval · 2015-11-24FDA Approved: XERESE — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for XERESE (acyclovir and hydrocortisone) by Bausch Health US LLC, resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores [Phase 2]
Phase 2 trial assessed safety and efficacy of Merlin, an ethanol and glycolic acid mixture, for treating recurrent herpes labialis (cold sor…
-
FDA approval · 2015-04-08FDA Approved: VALACYCLOVIR — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved Quallent Pharmaceuticals Health LLC's original ANDA for Valacyclovir, providing a generic option for treating common herpes inf…
-
FDA approval · 2014-10-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited, granting approval of a generic product…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old [Phase 3]
Open-label safety study of Xerese Cream for recurrent herpes labialis in children aged 6-11 was completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode [Phase 1]
Phase 1 exploratory trial from GlaxoSmithKline assessing the inflammatory response during a cold sore episode in herpes labialis. Results we…
-
FDA approval · 2013-07-23FDA Approved: FAMCICLOVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic famciclovir from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: NB-001 Treatment of Recurrent Herpes Labialis [Phase 3]
Phase 3 clinical trial update for NB-001 in recurrent herpes labialis is underway. The sponsor is NanoBio Corporation, but the current statu…
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) [Phase 3]
A Phase 3 multicenter study evaluating NB-001 for recurrent herpes labialis (SHaRCS) has completed.
-
FDA approval · 2013-05-14FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved a supplemental application for VALACYCLOVIR from Sun Pharmaceutical Industries, Inc., under an approved ANDA.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Phase 3 Clinical Study for the Treatment of Cold Sore [Phase 3]
Phase 3 clinical study for the treatment of cold sores has completed; results were posted on 2012-12-21.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Study of a Cold Sore Patch for the Treatment of Herpes Labialis [NA]
This clinical trial update notes the completion of a study evaluating a Cold Sore Patch for the treatment of herpes labialis.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis [Phase 2]
Phase 2 randomized, double-blind, crossover trial evaluating oral glutamine to suppress frequently recurrent herpes labialis; the study was …
-
FDA approval · 2012-01-12FDA Approved: FAMCICLOVIR — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original ANDA for famciclovir from Macleods Pharmaceuticals Limited, establishing a generic version of the antiviral. The d…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Study to Evaluate Using a Cold Sore Patch to Treat Herpes Labialis [NA]
A completed clinical study evaluated the use of a cold sore patch to treat herpes labialis, sponsored by Johnson & Johnson Consumer and Pers…
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Place Controlled Study to Treat Recurrent Herpes Labialis. [Phase 2]
A Phase 2, placebo-controlled study evaluating treatment for recurrent herpes labialis has completed.
-
FDA approval · 2011-05-09FDA Approved: FAMCICLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for famciclovir from Teva Pharmaceuticals USA, Inc., updating the regulatory status for the generic …
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers [Phase 4]
Phase 4 trial evaluating penciclovir 1% cream to prevent lesions in individuals with recurrent cold sores has completed and results have bee…
-
FDA approval · 2010-05-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Original Application (TIME CAP LABORATORIES, INC.)
FDA approved Valacyclovir hydrochloride from Time Cap Laboratories under an Original Abbreviated New Drug Application.